We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

DCOMP:NASDAQDime Community Bancshares, Inc. - Fixed-Rate Non-Cumulative Perpetual Preferred Stock, Series A Analysis

Data as of 2026-03-28 - not real-time

$18.67

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Dime Community Bancshares (DCOMP) trades around $18.67, delivering a trailing PE of roughly 5×, far below the regional‑bank industry average of 16×. The price‑to‑book ratio of 0.6 and a dividend yield of 7.44% further underscore the stock’s deep discount relative to peers. The balance sheet shows ample liquidity with over $2.4 bn in cash against less than $0.9 bn of debt, resulting in a near‑zero debt‑to‑equity ratio. Operating margins sit near 46% and profit margins at 27%, indicating a profitable core despite modest revenue growth of 1.6%. Recent corporate actions—including a planned name change to “Dime Commercial Bancshares” and a transfer of its listing to the NYSE—signal management’s intent to raise the company’s profile.
Technically, the stock is trading below its 20‑day (18.94), 50‑day (19.16) and 200‑day (19.05) simple moving averages, suggesting short‑term weakness. The RSI of 44.6 and a bearish MACD histogram reinforce a neutral‑to‑bearish momentum bias. Volume has been decreasing, and the 30‑day volatility of about 20% combined with a beta of 0.22 points to low market sensitivity but heightened price swings. Given the strong fundamentals and attractive yield, the valuation leans toward undervalued, while the technicals advise caution in the near term. Consequently, we recommend a hold for the next few weeks, transitioning to a buy stance for medium to long horizons as the price re‑aligns with its intrinsic value.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • price below key moving averages
  • bearish MACD momentum
  • decreasing volume

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • significant valuation discount
  • high dividend yield
  • strong cash position

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • stable earnings margins
  • low beta and defensive profile
  • strategic rebranding and NYSE listing

Key Metrics & Analysis

Financial Health

Revenue Growth159.40%
Profit Margin27.00%
P/E Ratio5.0
ROE7.71%
ROA0.74%
P/B Ratio0.6
Op. Cash Flow$186.6M
Industry P/E16.0

Technical Analysis

TrendNeutral
RSI44.6
Support$18.13
Resistance$19.50
MA 20$18.94
MA 50$19.16
MA 200$19.05
MACDBearish
VolumeDecreasing
Fear & Greed Index65.98

Valuation

GradeUndervalued
TypeValue
Dividend Yield7.44%

Risk Assessment

Beta0.22
Volatility20.26%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.